![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 24, 2021 1:51:15 PM
Very exciting https://money.cnn.com/quote/quote.html?symb=NPHC
I think more actually. This stock has multiple $15 billion to $100 billion markets. The MS market is $15 billion yearly and the pain killer market is well over $100 billion.
Big Pharma can easily acquire for $6 billion and still turn a profit in the same year.
As with all penny stocks they just have no infrastructure to effectively deliver the product to market.
It pretty obvious to me the only reason to get the filings current - which must be done for a stock acquisition and restating their patents and IP is to pave the way for a significant acquisition which could already be in discussions.
I honestly think $2-$5 share price is the target price for acquisition.
Load up now.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM